Crispr Therapeutics shares owned by Sittner & Nelson
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Sittner & Nelson
from 13F filings
Historical chart of Sittner & Nelson investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Sittner & Nelson consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Sittner & Nelson
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $327k | 5.1k | 64.81 |
| 2025-06-30 | $242k | 5.0k | 48.64 |
| 2025-03-31 | $149k | 4.4k | 34.03 |
| 2024-12-31 | $173k | 4.4k | 39.36 |
| 2024-09-30 | $176k | 3.7k | 46.98 |
| 2024-06-30 | $192k | 3.5k | 54.01 |
| 2024-03-31 | $262k | 3.8k | 68.16 |
| 2023-09-30 | $167k | 3.7k | 45.39 |
| 2023-06-30 | $199k | 3.5k | 56.14 |
| 2023-03-31 | $160k | 3.5k | 45.23 |
| 2022-12-31 | $139k | 3.4k | 40.65 |
| 2022-09-30 | $224k | 3.4k | 65.36 |
| 2022-06-30 | $208k | 3.4k | 60.69 |
| 2022-03-31 | $215k | 3.4k | 62.74 |
| 2021-12-31 | $207k | 2.7k | 75.91 |
| 2021-09-30 | $282k | 2.5k | 112.04 |
| 2021-06-30 | $264k | 1.6k | 161.96 |
| 2021-03-31 | $146k | 1.2k | 121.67 |